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OBJECTIVE: To determine whether the gross tumor volume of resectable gastric adenocarcinoma on
multidetector computed tomography could predict the presence of regional lymph node metastasis and could
determine N categories.
MATERIALS AND METHODS: A total of 202 consecutive patients with gastric adenocarcinoma who had
undergone gastrectomy 1 week after contrast-enhanced multidetector computed tomography were retro-
spectively identified. The gross tumor volume was evaluated on multidetector computed tomography images.
Univariate and multivariate analyses were performed to determine whether the gross tumor volume could
predict regional lymph node metastasis, and the Mann-Whitney U test was performed to compare the gross
tumor volume among N categories. Additionally, a receiver operating characteristic analysis was performed to
identify the accuracy of the gross tumor volume in differentiating N categories.
RESULTS: The gross tumor volume could predict regional lymph node metastasis (po0.0001) in the univariate
analysis, and the multivariate analyses indicated that the gross tumor volume was an independent risk factor for
regional lymph node metastasis (p=0.005, odds ratio=1.364). The Mann-Whitney U test showed that the gross
tumor volume could distinguish N0 from the N1-N3 categories, N0-N1 from N2-N3, and N0-N2 from N3 (all
po0.0001). In the T1-T4a categories, the gross tumor volume could differentiate N0 from the N1-N3 categories
(cutoff, 12.3 cm3), N0-N1 from N2-N3 (cutoff, 16.6 cm3), and N0-N2 from N3 (cutoff, 24.6 cm3). In the T4a
category, the gross tumor volume could differentiate N0 from the N1-N3 categories (cutoff, 15.8 cm3), N0-N1
from N2-N3 (cutoff, 17.8 cm3), and N0-N2 from N3 (cutoff, 24 cm3).
CONCLUSION: The gross tumor volume of resectable gastric adenocarcinoma on multidetector computed
tomography could predict regional lymph node metastasis and N categories.
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’ INTRODUCTION
Gastric cancer is one of the most common cancers and the
second most common cause of cancer-related mortality world-
wide, and most gastric cancers are gastric adenocarcinoma
(1,2). In the United States, 22,220 new cases of this malignancy
were estimated to have occurred in 2011, resulting in 10,990
expected deaths (3). Lymph node metastasis (LNM) is a well-
established critical prognostic factor, and accurate staging of
LNM is desirable for preoperative treatment (4,5). Accord-
ing to the 7th edition of the American Joint Committee
on Cancer (AJCC) staging system, released in 2010, at least
16 regional lymph nodes should be assessed pathologically
to determine the N category (6). Although an increasing
incidence of LNM has been observed in patients who
undergo extended lymphadenectomy, postoperative morbid-
ity and mortality remain high (7-9). Therefore, extended
lymphadenectomy cannot be recommended for the treat-
ment of all patients with gastric cancer, and accurate
noninvasive assessment of LNM and the N category plays
an important role in determining whether these patients
should undergo complete resection of the primary tumor and
more extensive lymphadenectomies.DOI: 10.6061/clinics/2016(04)04
Copyright & 2016 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons License (http://creativecommons.org/licenses/by/
4.0/) which permits unrestricted use, distribution, and reproduction in any
medium or format, provided the original work is properly cited.
No potential conflict of interest was reported.
199
CLINICAL SCIENCE
Currently, the tools for preoperative assessment of LNM
and the N category of gastric cancer include endoscopic
ultrasonography (EUS), computed tomography (CT) and
positron emission tomography/computed tomography
(PET/CT). EUS can distinguish the different layers that
compose the gastric wall and can be used to visualize the
perigastric lymph nodes via a miniaturized ultrasonography
(US) probe. However, this approach is invasive and lacks the
capacity for panoramic investigation, and a sufficiently
stenotic stomach may prevent passage of the endoscope.
A previous study reported that the diagnostic performance
of EUS for LNM identification is relatively unreliable, and
the overall accuracy of EUS in determining the N category
was only 66% in another study (10,11). In the latter study, on
CT, lymph nodes were considered positive for metastasis if
they were X8 mm along the short-axis diameter (11).
Because CT could not reliably detect small LNM, the
diagnostic accuracy was approximately 62.8% (11). In
addition, PET/CT can help to assess regional LNM, but
with a low diagnostic accuracy, or 58%, because PET/CT
cannot detect regional LNM in patients with early gastric
cancer (12). Previous studies have shown that the gross
tumor volume (GTV) of esophagogastric junction adenocar-
cinoma and esophageal cancer measured on multidetector
computed tomography (MDCT) is associated with regional
LNM and N categories (13,14). Hallinan et al also reported
that the GTV was moderately accurate in predicting the N
stage (15). To our knowledge, however, there have been no
reports regarding the utility of the GTV of resectable gastric
adenocarcinoma measured on MDCT in predicting regional
LNM and N categories. Thus, we aimed to retrospectively
assess whether the GTVof resectable gastric adenocarcinoma
measured on MDCT could predict regional LNM and
N categories.
’ MATERIALS AND METHODS
This study was approved by the institutional ethics
committee, and written informed consent was obtained from
each patient.
A total of 250 consecutive patients with gastric adenocar-
cinoma diagnosed at our institution were retrospectively
recruited into the study between June 2013 and July 2014.
Of the 250 participants, 17 patients who had not undergone
surgery, including 3 patients with other severe disease,
8 patients with distant metastasis, and 6 patients with direct
invasion of an adjacent organ; 26 patients who had under-
gone radiation therapy and preoperative neoadjuvant
chemotherapy; and 5 patients who had images of poor
quality, were excluded from this study. Consequently, this
study involved 202 patients.
In total, 141 of the 202 patients (69.8%) were males (median
age, 61 years; age range, 22-79 years), and 61 (30.2%) were
females (median age, 60 years; age range, 33-78 years). All
patients underwent endoscopic biopsy and preoperative
contrast-enhanced CT. Subsequently, the included patients
underwent standard operative procedures: namely, distal
subtotal or total gastrectomy with D2 or more extended
lymphadenectomy. The interval between CT and surgery was
less than one week. Among the 202 patients, a total of 3756
lymph nodes were removed, with a mean of 18 nodes (range,
q7-30) for each patient. According to the postoperative
pathologic examination, 136 patients had LNM, whereas 66
patients did not. According to the postoperative histopathology
and AJCC criteria (6), the tumors were located in the upper
one-third of the stomach in 55 patients, the middle one-third
in 50 patients and the lower one-third in 97 patients. Tumor
histology was classified into two groups: the differentiated
group (well- or moderately differentiated adenocarcinoma)
in 129 patients and the undifferentiated group (poorly diff-
erentiated adenocarcinoma) in 73 patients. Primary tumors
were classified as being in the T1 category in 19 patients,
the T2 category in 40, the T3 category in 15, and the T4a
category in 128. The dissected lymph nodes were classi-
fied into the N0 category in 66 patients, the N1 category
in 39, the N2 category in 43, and the N3 category in 54.
The presence of vascular or lymphatic invasion was observed
in 81 patients.
Contrast-enhanced MDCT
All patients were scheduled to undergo enhanced 64-section
MDCT (Light-Speed VCT; General Electric Health Care,
Chalfont St. Giles, United Kingdom). Before CT image
acquisition, the patients ingested effervescent granules along
with 500 mL of water to distend the stomach with gas. The
patients were then examined by CT, and the CT data
acquisition was performed in the arterial phase (25-30 s) and
the portal-venous phase (60-70 s), covering the entire stomach
in the arterial phase and the entire abdomen and pelvis after
injection of contrast material (Ultravist 300, Iopamidol; Bayer
Healthcare, Berlin, Germany). The CT scanning variables were
120 kVp, 200-380 mA, a section thickness of 2 mm, and a
reconstruction interval of 2 mm. Scanning was performed
during the arterial and portal venous phases, and the an
atomic coverage was from the apex of the lungs to the pelvic
cavity. The data were directly interfaced and forwarded to the
General Electric Advantage Workstation 4.4 (Advantage Work-
station version 4.4; General Electric Healthcare).
GTV measurement
The GTV was measured at a window width of 380 HU and
a window level of 50 HU. In particular, the GTV was obtained
by multiplying the sum of all tumor areas by the section
thickness according to a protocol in a previous report
(13,16,17). For delineation of the tumor area, a gastric wall
thickness X5 mm on transverse imaging with the stomach
distended was regarded as abnormal (18). The tumor area was
depicted on each axial enhanced CT image (Figure 1) and was
automatically calculated by the software. After assessing the
whole tumor, each contiguous transverse tumor area was
summed to obtain the GTV. The time needed to obtain the
GTV was approximately 200 s on average (range, 100-350 s).
To maintain the accuracy of the measurements, 2 experi-
enced radiologists working in consensus were trained in
measuring the GTV randomly in another 20 patients by a
radiologic professor. All tumor measurements were repeated
one month later to test the interobserver reproducibility of
the measurement of the GTV.
Statistical analysis
All statistical analyses were carried out with SPSS (version
17.0, SPSS, Chicago, IL, United States). Po0.05 was
considered to represent a significant difference.
The CT data of the 202 patients with gastric adenocarci-
noma were used to test the interobserver reproducibility
of the measurements. In these 202 patients, the precision of
the replicated GTV measurements was assessed using the
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coefficient of variation (CV) (standard deviation / mean 
100). When the %CV was less than 10%, interobserver
variability was considered to be small, and the averaged
value of the two observers’ measurements was regarded as
the final GTV. If the %CV exceeded 10%, another two
measurements were performed by the previous observers,
and the average of the four measurements was used as the
final GTV.
Univariate associations between LNM and both the GTV
and clinicopathological factors were analyzed using the chi-
square test (or Fisher’s exact test when appropriate). Multi-
variate logistic regression analyses were used to assess the
associated risk factors for LNM. GTV values were compared
between patients stratified by N category using non-
parametric Mann-Whitney U tests together with Bonferroni
correction for multiple comparisons. A receiver-operating
characteristic (ROC) analysis was also performed to deter-
mine the threshold GTV values for differentiation of N
categories.
’ RESULTS
Interobserver variability of measuring
tumor volume
For the first evaluation in this cohort, the mean GTV was
32.25±29.25 cm3 (range, 2.3-189.3 cm3). For the repetitive
measurement, the mean GTV was 30.89±27.43 cm3 (range,
2.5-191.6 cm3). As for the precision of the CT measurements
of the GTV, the CV was 5% (range, 1-14.6%). Therefore, the
CV was less than 10%, and the interobserver variability of
the GTV measurement was small, so the average value of the
two measurements was regarded as the final GTV. However,
for the two measurements in four patients, the CV exceeded
10; therefore, two additional measurements were obtained,
and the average of the four measurements was used as the
final GTV.
Univariate and multivariate analyses of correlation
of both clinicopathological factors and GTV
with LNM
Based on the possible clinicopathological factors for predict-
ing LNM, including age, gender, anatomical distribution,
histologic type, T category, GTV and lymphatic or vascular
invasion, the details of the univariate analysis are illustrated in
Table 1. Based on the univariate analysis, histologic type,
T category, GTV and lymphatic or vascular invasion showed
an association with LNM. In particular, LNM was found more
frequently in the patients with an undifferentiated histologic
type than in those with a differentiated histologic type
(p=0.004), in patients with a deeper tumor depth than in those
with a lesser tumor depth (po0.0001), in patient with a GTV
X14.5 cm3 than in those with a GTV o14.5 cm3 (po0.0001),
and in patients with lymphatic or vascular invasion than in
those without this invasion (po0.0001). However, there were
no significant associations between LNM and age, gender, or
tumor anatomical distribution (p=0.506, 0.185, and 0.062,
respectively).
Regarding the multivariate analysis, T category, GTV and
lymphatic or vascular invasion were found to be independentFigure 1 - Transverse contrast-enhanced multidetector computed
tomography (CT) images in a 55-year-old man (a) and a 65-year-
old man (b) with gastric adenocarcinoma. The tumor area (S)
is depicted on the axial contrast-enhanced CT image. Table 1 - Univariate analysis of clinicopathological factors and
gross tumor volume correlated with regional lymph node
metastasis.
Variable Lymph node metastasis p value
Negative
(n=66)
Positive
(n=136)
Age* 58.63±10.13 59.58±10.89 0.506
Gender 0.185
Male 43(65.1) 98(72.1)
Female 23(34.9) 38(27.9)
Anatomical distribution 0.062
Upper 1/3 18(27.3) 37
Middle 1/3 38(57.6) 12
Lower 1/3 10(15.1) 87
Histologic type 0.004
Differentiated 33(50) 96(70.6)
Undifferentiated 33(50) 40(29.4)
T category o0.0001
T1 18(27.3) 1(0.7)
T2 28(42.4) 12(8.8)
T3 6(9) 9(6.6)
T4a 14(21.3) 114(83.9)
Gross tumor volume (cm3) o0.0001
o14.5 55(83.3) 32(23.5)
X14.5 11(16.7) 104(76.5)
Lymphatic or vascular
invasion
o0.0001
Absent 63(95.4) 58(42.6)
Present 3(4.6) 78(57.4)
Note: The numbers in the parentheses are percentages.
* The data are the median ± standard deviation.
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risk factors for LNM. The GTV (p=0.005, odds ratio (OR)=1.364,
and 95% confidence interval (CI) for OR of 1.015-2.438), T stage
(po0.0001, OR=2.337, and 95% CI of 1.519-3.596) and
lymphatic or vascular invasion (po0.0001, OR=9.886, and
95% CI of 2.505-39.24) of the primary tumor were associated
with regional LNM.
Correlation between N categories and GTV
Table 2 summarizes the correlation between the N
categories and the GTV. The GTV could help to distinguish
the N1 from the N2 category (p=0.004), N1 from N3
(po0.0001), N2 from N3 (po0.0001), N0 from N1-N3
(po0.0001), N0-N1 from N2-N3 (po0.0001), and N0-N2
from N3 (po0.0001).
In addition, most of the patients in our study were in the
T4a category. Therefore, we focused on investigating the
GTV in the patients in the T4a category according to
N categories (Table 2). In total, 114 of the 128 patients
(89.1%) had LNM, and 14 of the 128 patients (10.9%) did not
have LNM. In all, 26 of the 114 patients were classified into
the N1 category, 39 patients were classified into the N2
category, and 49 patients were classified into the N3 category.
In the T4a category, the GTV could help to distinguish
between N1 and N2 (p=0.015), N1 and N3 (po0.0001), N2
and N3 (po0.0001), N0 and N1-N3 (po0.0001), N0-N1 and
N2-N3 (po0.0001), and N0-N2 and N3 (po0.0001).
ROC analyses of accuracy of GTV of gastric
adenocarcinoma in differentiating N categories
Using ROC analysis of the T1-T4a categories, we found
that the GTV could help to differentiate N0 from the N1-N3
categories (cutoff, 12.3 cm3), N0-N1 from the N2-N3 (cutoff,
16.6 cm3), and N0-N2 from N3 (cutoff, 24.6 cm3) (Figure 2).
In the T4a category, the GTV could help to differentiate N0
from the N1-N3 categories (cutoff, 15.8 cm3), N0-N1 from
N2-N3 (cutoff, 17.8 cm3), and N0-N2 from N3 (cutoff, 24 cm3)
(Figure 3). The diagnostic efficiency, as assessed based on the
area under the ROC curve, sensitivity, specificity, the positive
predictive value, the negative predictive value and the
accuracy of the GTV in differentiating the N categories, is
shown in Table 3.
’ DISCUSSION
LNM is known to be one of the major negative prognostic
factors for patients with resectable gastric cancer after
curative surgery (19). Radical gastrectomy with removal of
regional lymph nodes has been considered as the standard
for the treatment of curable gastric cancer (20). However, for
many years, it has been debated whether extended lymph
node dissection is beneficial for gastric cancer. Recently,
D2 lymphadenectomy has become the standard treatment
for curable gastric cancer in eastern Asia (21). However,
previous research has shown that patients with advanced
gastric cancer benefit from more extensive lymph node
dissection (22). Moreover, extended lymphadenectomy may
detect small LNM that is difficult to diagnose preoperatively.
Theoretically, removal of a wider range of lymph nodes
improves staging accuracy and increases the chances for
cure, but its contribution to prolonged survival remains
unclear. More extensive surgery can also contribute to more
operation-related complications and mortality. Moreover,
previous studies reported that neoadjuvant chemotherapy
could help to decrease the N categories before surgical
resection (23,24). Therefore, it is essential to accurately
preoperatively diagnose LNM and the N category to
determine whether patients with gastric cancer should
receive gastrectomy alone or combined with D2 lymphade-
nectomy or more extensive lymphadenectomies and/or
neoadjuvant chemotherapy before surgery. Most variables
related to lymph node evaluation are pathological because it
is very difficult to establish the N category preoperatively. At
present, EUS, MDCT and PET/CT for diagnosis of the
presence of LNM and determination of the N category are
not the most reliable imaging modalities. In the current
study, we retrospectively assessed the GTV of gastric cancer
measured on MDCT and found that the GTV can be utilized
to predict the presence of LNM and to determine the N
category with a better diagnostic accuracy.
Previous studies have been performed to evaluate the risk
of LNM in gastric cancer. Several prognostic factors,
including depth of invasion, vascular invasion or lymphatic
permeation, and tumor histologic type, have been demon-
strated to be related to LNM in gastric cancer (19,25). Our
study was consistent with these published reports. Certain
studies have also reported that the GTV of esophageal
squamous cell carcinoma and esophagogastric junction
adenocarcinoma measured by CT or PET/CT is associated
with regional LNM (13,14,26). Therefore, we wondered if the
GTV of gastric cancer on CT could be helpful predicting
regional LNM. In the present study, we found that the GTV
remained an independent factor for predicting LNM when
the T stage and the GTV were included in a multivariate
model. Moreover, another study reported that the GTV was
an important prognostic factor in patients who underwent
curative resection for gastric cancer (27). It is also well known
that LNM is one of the major negative prognostic factors for
patients with resectable gastric cancer after curative surgery
(19). Taking these findings into consideration, we presume
that one of the key reasons for the GTV being an important
prognostic factor in patients is its influence on regional LNM.
This hypothesis should be confirmed in a future study.
The prediction of regional LNM in gastric cancer by EUS,
CT and PET/CT has been studied. Mocellin et al reported
that EUS had high diagnostic efficiency in staging the
T category but that it was less reliable in predicting LNM,
with a sensitivity of 0.69 and a specificity of 0.84 (10). Hwang
et al reported that detection of LNM by EUS was effective in
70.4% of cases (sensitivity: 19.3%, specificity: 96.3%) (11).
Recently, MDCT scanners have begun to be widely used
worldwide, allowing more detailed imaging with thinner
section collimation. Certain previous investigators relied on
different lymph node morphologic criteria for predicting
Table 2 - Gross tumor volume of resectable gastric
adenocarcinoma in patients stratified by N category.
N category T1-T4a categories (n=202) T4a category (n=128)
N0 5.40(2.98, 9.45) 11.47(3.56, 19.37)
N1 15.47(4.48, 20.87) 16.50(6.77, 24.75)
N2 26(15.20, 33.60) 26.25(15.75, 39.60)
N3 48.75(27, 110) 50.47(27, 112.77)
N0-N1 6.90(3.27, 15.75) 15.20(4.50, 23.50)
N0-N2 11.01(4.40, 23.50) 16.87(11.73, 32.12)
N1-N3 26.60(15.2, 48.56) 30(16, 52.9)
N2-N3 32.25(19.68, 61.20) 33(20.44, 72)
Note: The data are presented as the median (25th percentile, 75th
percentile).
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LNM, although with accuracy remaining approximately
70% (11,28). As for PET/CT, Kim et al reported that the
specificity was 100% for predicting LNM, although the
sensitivity was low (41%) and the accuracy was 51% (29). In
the present study, we found that the GTV measured on
MDCTcould help to predict LNMwith a sensitivity of 81.6%,
a specificity of 83.3% and an accuracy of 81.2%.
In the past, the patients with gastric category in the T4
category did not receive surgery (30). Recently, however,
these patients have begun to receive surgery. According to
previous reports, preoperative prediction of the presence of
LNM and the number of lymph node metastases for T4
tumors is of particular importance in determining tumor
resectability and the optimal extent of surgery (31,32).
Because of the significant difference in the GTV of gastric
cancer between N categories, we assessed whether the GTV
can differentiate N categories within the T1-T4a categories.
There were 128 patients in the T4a category in our study, so
we also specifically used the GTV to differentiate N
categories only in T4a category. For the T1-T4a categories,
we found that the GTV could help to differentiate N0 from
the N1-N3 categories (cutoff, 12.3 cm3), N0-N1 from N2-N3
(cutoff, 16.6 cm3), and N0-N2 from N3 (cutoff, 24.6 cm3).
Additionally, in the present study, the accuracies of the GTV
were higher than in a previous report (15) in terms of
differentiating N0 from the N1-N3 categories (81.2% vs 75%),
N0-N1 from N2-N3 (78.7% vs 74%), and N0-N2 from N3
(76.2% vs 75%). This difference may be due to the facts that
the sample size in the current study was larger than that in
the previous study and that there were many patients in the
T4a category. In the T4a category in particular, the GTV
could help to differentiate N0 from the N1-N3 categories
(cutoff, 15.8 cm3), N0-N1 from N2-N3 (cutoff, 17.8 cm3), and
N0-N2 from N3 (cutoff, 24 cm3). The potential mechanism for
the effect of the GTVon N categories could be that the larger
the GTV is; the deeper the tumor invasion of several layers of
the stomach is; the more likely this invasion is to involve
lymphatics in the submucosal layer; and therefore, the more
frequent the incidence of LNM is.
There were several limitations in this study. First, this was a
retrospective study. Additionally, we did not apply the
thresholds identified in the current study to a completely
new patient population and compare the preoperative
N categories to the postsurgical staging and then calculate
the accuracy of our recommended CT methodology. Second,
it was occasionally difficult to distinguish tumors from
neighboring organs, especially for tumors in the T4a category.
To minimize this effect, each patient ingested effervescent
granules within 10 mL of water to distend the stomach with
gas before CT. Third, the 202 patients included in this study
had an indication for surgery, whereas patients who had a
contraindication for surgery were excluded from this study.
However, our findings are applicable to resectable gastric
adenocarcinoma. Finally, there was large variation of the GTV
CI in the categories, and the OR of the GTV was only 1.364 in
the multivariate analysis. The probable reason for these
features is our relatively small sample size. Therefore, a larger
sample size should be examined to validate our research in
the future. Despite these limitations, all of the enrolled cases
were staged based on postoperative histopathology, and our
Figure 2 - Receiver operating characteristic (ROC) curves of the accuracy of the gross tumor volume (GTV) in differentiating N categories
in patients with resectable gastric adenocarcinoma in the T1-T4a categories. The ROC curve shows that the GTV could help to
differentiate N0 from N1-N3 (A), N0-N1 from N2-N3 (B), and N0-N2 from N3 (C) by using GTV cutoff values of 12.30 cm3, 16.65 cm3 and
24.60 cm3, respectively.
Table 3 - Receiver operating characteristic analysis of accuracy of gross tumor volume of resectable gastric adenocarcinoma in
detecting N categories.
Gross tumor volume cutoff N category comparisons AUC Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
T1-T4a categories (n=202)
12.30(cm3) N0 vs N1-N3 0.870 81.6 83.3 90.8 67 81.2
16.65(cm3) N0-N1 vs N2-N3 0.878 80 77.9 77.2 80.2 78.7
24.60(cm3) N0-N2 vs N3 0.869 76.4 76.5 60 89.3 76.2
T4a category (n=128)
15.79(cm3) N0 vs N1-N3 0.790 77.2 78.6 96.7 30 77.3
17.75(cm3) N0-N1 vs N2-N3 0.800 79.8 72.8 86.5 60.9 77.3
24.00(cm3) N0-N2 vs N3 0.807 80 67 56.3 82.4 67.9
Note: AUC = area under the receiver operating characteristic curve, PPV = positive predictive value, NPV = negative predictive value.
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study demonstrated the potential use of MDCT as a tool to
measure the GTV to predict LNM and to determine N
categories. We will focus on our recommended thresholds for
the GTV to predict the presence of LNM and to determine N
categories in a second, prospective study.
In conclusion, we found that the GTV of resectable gastric
adenocarcinoma measured on MDCT was associated with
the presence of regional LNM and with N categories. In the
T1-T4a categories, a sensitivity, a specificity and an accuracy
of more than 76% were calculated by using GTV thresholds
of 12.30 cm3, 16.65 cm3, and 24.60 cm3 for differentiating
N0 from N1-N3, N0-N1 from N2-N3, and N0-N2 from
N3, respectively. In the T4a category, GTV thresholds of
15.79 cm3, 17.75 cm3, and 24.0 cm3 could help to differentiate
N0 from the N1-N3 categories, N0-N1 from N2-N3, and
N0-N2 from N3, respectively. We believe that the GTV could
help clinicians to quantitatively predict the presence of LNM
and to determine N categories when choosing the optimal
treatment modalities for individual cases.
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